Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Sarcoma 1Liposarcoma 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 108Magnetic Resonance Spectroscopy 77Biopsy 76pembrolizumab 59Cyclophosphamide 49fludarabine 40Carboplatin 25Nivolumab 24Cetuximab 23venetoclax 21Radiotherapy 21Cisplatin 21Bevacizumab 20atezolizumab 18X-Rays 18Radiation 17Ipilimumab 17fludarabine phosphate 16Fluorouracil 16Gemcitabine 15Temozolomide 14Paclitaxel 14Leucovorin 14Irinotecan 14Cytarabine 14durvalumab 13Pemetrexed 13Azacitidine 13Oxaliplatin 12CTLA-4 Antigen 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Histamine H2 Antagonists × 30 days × Clear all
NCT06789172 2026-05-22

INVOKE

Epkin

Phase 1 Recruiting
166 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Liposarcoma, Sarcoma, Colorectal Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡